![Radoslaw Janiak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Radoslaw Janiak
Chief Executive Officer at Future Meds Ltd.
Radoslaw Janiak active positions
Companies | Position | Start | End |
---|---|---|---|
Synexus Clinical Research Ltd.
![]() Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Chief Operating Officer | 2016-12-31 | - |
Corporate Officer/Principal | 2005-12-31 | - | |
President | 2016-12-31 | - | |
Synexus Clinical Research GmbH
![]() Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010. | Chief Executive Officer | - | - |
Future Meds Ltd.
![]() Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Chief Executive Officer | 2019-09-30 | - |
Career history of Radoslaw Janiak
Statistics
International
United Kingdom | 3 |
Germany | 2 |
Operational
Chief Executive Officer | 2 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Synexus Clinical Research Ltd.
![]() Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Health Services |
Synexus Clinical Research GmbH
![]() Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010. | Commercial Services |
Future Meds Ltd.
![]() Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Commercial Services |
- Stock Market
- Insiders
- Radoslaw Janiak
- Experience